Your browser doesn't support javascript.
loading
Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
Gregg, Kelsey A; Harberts, Erin; Gardner, Francesca M; Pelletier, Mark R; Cayatte, Corinne; Yu, Li; McCarthy, Michael P; Marshall, Jason D; Ernst, Robert K.
Afiliação
  • Gregg KA; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
  • Harberts E; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
  • Gardner FM; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
  • Pelletier MR; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
  • Cayatte C; Vaccine Platform Group, MedImmune, Gaithersburg, Maryland, USA.
  • Yu L; Statistical Sciences, MedImmune, Gaithersburg, Maryland, USA.
  • McCarthy MP; Vaccine Platform Group, MedImmune, Gaithersburg, Maryland, USA.
  • Marshall JD; Vaccine Platform Group, MedImmune, Gaithersburg, Maryland, USA.
  • Ernst RK; Department of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA rkernst@umaryland.edu.
mBio ; 8(3)2017 05 09.
Article em En | MEDLINE | ID: mdl-28487429

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Lipopolissacarídeos / Receptor 4 Toll-Like / Descoberta de Drogas / Lipídeo A Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: MBio Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Adjuvantes Imunológicos / Lipopolissacarídeos / Receptor 4 Toll-Like / Descoberta de Drogas / Lipídeo A Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: MBio Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos